文献名
|
提交时间
|
查询结果
|
回复时间
|
Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: reviewing the procedure
|
2015-03-02 10:15:01
|
已发送至邮箱
|
2015-03-02 10:39:37
|
Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations
|
2015-03-02 10:14:25
|
已发送至邮箱
|
2015-03-02 10:32:35
|
Intradetrusor onabotulinumtoxinA for overactive bladder
|
2015-03-02 10:12:43
|
暂时未查到相关文献
|
2015-03-02 10:25:58
|
Cost-effectiveness of novel therapies for overactive bladder.
|
2015-03-02 10:12:02
|
暂时未查到相关文献
|
2015-03-02 10:22:41
|
Reduced glomerular epithelial proteinl expression and podocyte injury in immunoglobul in a nephropathy
|
2015-03-01 20:17:49
|
已发送至邮箱
|
2015-03-02 09:40:38
|
.Expression of podocyte associated molecules in acquired human kidney diseases
|
2015-03-01 20:17:28
|
已发送至邮箱
|
2015-03-02 09:43:06
|
Expression of alpha-actinin- 4 in acquired human nephrotie syndrome :aquantitative immunoelectronm icroscopy study
|
2015-03-01 20:17:06
|
已发送至邮箱
|
2015-03-02 09:44:50
|
The podocyte’s reponse to injury:role in proteinuria and glomerlosclerosis
|
2015-03-01 20:16:52
|
暂时未查到相关文献
|
2015-03-02 09:47:36
|
Gene expression profiles of podocyte associated molecules as diagnostic markers in acquired proteinuric diseases [
|
2015-03-01 20:16:39
|
已发送至邮箱
|
2015-03-02 09:50:14
|
Nephrin and podocin d issociate at the onset of proteinuria in experimental membranous nephropathy
|
2015-03-01 20:16:26
|
已发送至邮箱
|
2015-03-02 09:53:14
|